Skip to main content

Analytics

By Jack McCarthy | 09:03 am | August 03, 2015
To be maximally effective, policymakers are going to have to modernize the regulatory system so it can support big data analytics for genomic research.
By Gregory Berg | 12:25 pm | July 17, 2015
In an industry under pressure to contain costs and improve outcomes, big data is proving to be a valuable asset. But data alone can't move the needle. It's all about how it's analyzed to drive smarter decisions.
By Michael Simon | 06:39 pm | July 09, 2015
Health organizations are often moving too quickly from EHR implementation to population health and risk-based contracts, glossing over (or skipping entirely) the crucial step of evaluating the quality of the data they're using.
By John Halamka | 05:02 pm | June 18, 2015
With Stage 2 meaningful use, ICD-10, the HIPAA Omnibus Rule and the Affordable Care Act dominating the agenda these past few years, Beth Israel Deaconess CIO John Halamka, MD, is doing some research to help reshape next priorities.
By Bernie Monegain | 11:32 am | May 26, 2015
Oncology focused health IT companies Varian Medical Systems and Flatiron Health have forged an alliance aimed at eradicating cancer sooner rather than later.
By Tom Sullivan | 09:09 am | May 26, 2015
There are as many definitions for the phrase as there are people willing to address the question. But within those are some common characteristics that can be boiled down for further understanding.
By Erin McCann | 05:33 pm | May 20, 2015
Chicago's Advocate Health Care has 13 hospitals and one of the largest accountable care organizations in the U.S. With population health management at the center of ACO success, it is well acquainted with using analytics for quality improvement.
By Mike Miliard | 12:05 pm | May 20, 2015
As it aims to broaden its predictive analytics and personalized health capabilities, Welltok, developer of the CaféWell health optimization platform, has acquired Burlington, Mass.-based Predilytics.
By Tom Sullivan | 09:00 am | May 20, 2015
As the healthcare industry moves toward a more precise definition of its biggest new buzzword, providers and payers are facing some serious technical and political challenges as they embrace population health management.
By Bernie Monegain | 05:54 pm | May 14, 2015
Mayo Clinic will collaborate with Baylor College of Medicine to launch a study of 10,000 Mayo biobank members for potential risk of drug reactions or lack of drug effect based on each individual's genome.